Roche’s Breast Cancer Drug Perjeta Receives Green Light From EU
Today, Roche declared that the European Union gave a positive recommendation for the use of Perjeta (pertuzumab) in combination with
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓